The market for cold and flu medications is led by global pharmaceutical giants. Many established players have substantial shares in this competitive landscape, such as Johnson & Johnson, Novartis, and Sanofi. They owe their positions to their widespread geographical presence, robust product portfolio and strong R&D capabilities. These multinational corporations...
Discover more insightsAs the global community grapples with the ongoing pandemic, the pharmaceutical industry is at the forefront in the battle against the novel coronavirus. A crucial avenue of attack is the development of antiviral drugs that target specific proteins within the coronavirus structure. These proteins are vital for the virus's life...
Discover more insightsThe Active Pharmaceutical Ingredients (API) market displays robust advancement, propelled by the global health emergency triggered by the COVID-19 pandemic. The need for drugs to treat an unprecedented number of patients has spurred manufacturers to ramp up production, leading to an intensified demand for APIs. The COVID-19 related APIs currently...
Discover more insightsThe continual development and rapid deployment of COVID-19 therapies have underpinned a significant portion of healthcare industry activity. Immediate need and intensity of global efforts have sparked unprecedented levels of innovation in virus mitigation techniques, testing methods, and potential cures; a trajectory that is projected to sustain into the foreseeable...
Discover more insightsThe medical industry is undergoing evolutionary transformations with a focus on combatting the contagious ailment, Respiratory Syncytial Virus (RSV). The disease affects a significant population across the globe, necessitating groundbreaking techniques for alleviating suffering. With the inclusion of pioneering studies and novel therapies being developed, the segment is gaining substantial...
Discover more insights